Flowchart of study design. Patients receiving allo-HSCT with suspected TA-TMA were retrospectively identified from 2010 to 2018. The diagnosis was reviewed according to published criteria. *Evidence of microangiopathy was defined as the presence of schistocytes in a peripheral blood smear or histologic evidence of microangiopathy on tissue biopsy.